Michael Nierenberg
Analyst
So, good morning, Henry. [indiscernible] as well. When we look at opportunities, the consumer space there, what I would call, very live opportunities for us over the next couple of weeks that we're looking at. Keep in mind, as I went through our chronology of, what I would call, our early years of being born, there was a large transaction around SpringCastle where we bought a large portfolio of consumer loans. If you look at the Prosper deal, as I pointed out that we did with [Suros] (ph) and others, that was another very good transaction. So the consumer stuff we know extremely well and that will be front and center here over the next couple of weeks. I think the Genesis type loans that you see at some of the regional banks, again, those will be front and center for us as well. All of these things yielding with proper financing are in and around 15% to 20% at least. So we're really excited about those opportunities. On the mortgage company side, there's a couple, what I would call, mortgage company light things out there that we've looked at over time. We'll continue to look at that. On the commercial real estate space, during the quarter we put out, I think, something around $50 million of net dollars on, what I would call, one distressed property, as well as something around a development deal, around multifamily. So getting more active there. I would say on the commercial side, we need to be really patient. When loans go delinquent, banks don't hold on to delinquent loans, so those will come out over time. When you look at the regional side, the banks are going to pull back, there's a lot of assets out there. On the signature side, [Newmark] (ph) has been -- I think it’s Newmark, has been hired by the FDIC to sell assets there. So you're going to see plenty of opportunities to deploy capital. And it could range from consumer to real estate to residential side as well as on the commercial side. So realistically, anywhere where we think there's, what I would call, outsized opportunities for higher ROEs Measuring appropriate risk returns, that's where we'll head.